Is testis-sparing surgery safe in small testicular masses? Results of a multicentre study
- PMID: 28360955
- PMCID: PMC5365384
- DOI: 10.5489/cuaj.4016
Is testis-sparing surgery safe in small testicular masses? Results of a multicentre study
Abstract
Introduction: Our goal was to evaluate benign and malignant lesions and testicular intraepithelial neoplasia (TIN) in the neighbouring normal-appearing testis tissue in men who underwent radical orchiectomy for testicular mass with a pathologic tumour size of ≤3cm.
Methods: In this retrospective, multicentre study, data of 252 patients from 11 different institutions were included. Patients were divided into three groups based on tumour size: Group 1 (0-1 cm; n=35), Group 2 (1.1-2cm; n=99), and Group 3 (2.1-3 cm; n=118). Benign lesions and TIN were sought in the neighbouring testicular tissue and compared between groups.
Results: Mean patient age was 32.3 years. Benign lesions were reported in 54.3%, 33.3%, and 14.4% of Groups 1, 2, and 3, respectively (p<0.05 between groups). TIN was detected in 20%, 42.4%, and 41.5% of Groups 1, 2, and 3, respectively (p<0.05 for Group 1 vs. Groups 2 and 3; p>0.05 for Groups 2 vs. 3). Multifocality was detected in 8.6%, 4%, and 0% of Groups 1, 2, and 3, respectively (p<0.05 for both Group 1 vs. Group 3 and for Group 2 vs. Group 3; p>0.05 for Group 1 vs. Group 2). A tumour cutoff size of 1.5 cm was found to be significant for detecting benign tumour. TIN and multifocality rates were similar in patients with a tumour size of ≤1.5 vs. >1.5 cm (p>0.05).
Conclusions: Benign lesions and TIN in the neighbouring testis were significantly decreased and multifocality was increased in patients with a tumour mass size of ≤1 cm. Testis-sparing surgery should be performed with caution and a safety rim of normal tissue should also be excised.
Figures


References
-
- La Vecchia C, Bosetti C, Lucchini F, et al. Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol. 2010;21:1323–60. https://doi.org/10.1093/annonc/mdp530. - DOI - PubMed
-
- Engholm G, Ferlay J, Christensen N, et al. NORDCAN—a Nordic tool for cancer information, planning, quality control, and research. Acta Oncol. 2010;49:725–36. https://doi.org/10.3109/02841861003782017. - DOI - PubMed
-
- Klatte T, de Martino M, Arensmeier K, et al. Management and outcome of bilateral testicular germ cell tumours: A 25-year, single-centre experience. Int J Urol. 2008;15:821–6. https://doi.org/10.1111/j.1442-2042.2008.02107.x. - DOI - PubMed
-
- Heidenreich A, Weissbach L, Höltl W, et al. German Testicular Cancer Study Group. Organ-sparing surgery for malignant germ cell tumour of the testis. J Urol. 2001;166:2161–5. https://doi.org/10.1016/S0022-5347(05)65526-7. - DOI - PubMed
-
- Albers P, Albrecht W, Algaba F, et al. Guidelines on testicular cancer: 2015 update. Eur Urol. 2015;68:1054–68. https://doi.org/10.1016/j.eururo.2015.07.044. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources